Product ID: SQMIG35A2310
Global Doxorubicin Market Size, Share, Growth Analysis, By Type(Conventional Doxorubicin formulation and liposomal Doxorubicin formulations) - Industry Forecast 2024-2031
Report ID:
SQMIG35A2310 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|
Tables:
34 |
Figures:
74
Global Doxorubicin Market Insights
Doxorubicin Market size was valued at USD 0.9 billion in 2021 and is poised to grow from USD 1.1 billion in 2022 to USD 1.7 billion by 2030, growing at a CAGR of 5.8% in the forecast period (2023-2030).
The global doxorubicin market is experiencing substantial growth and is expected to continue its upward trajectory in the coming years. Doxorubicin is a widely used chemotherapy drug that is mainly used in the treatment of various types of cancers, including ovarian cancer, soft tissue sarcomas, breast cancer, lung cancer.
The market is determined by the increasing occurrence of cancer worldwide and the growing demand for effective cancer treatment options. Moreover, advancements in drug delivery systems and combination treatments are further fueling the market growth.
Though, the market is also played with challenges such as the high cost of treatment, the emergence of alternative therapies, and potential side effects of the drug. Despite these challenges, the increasing focus on personalized medicine and targeted therapies is predicted to create lucrative prospects for the Doxorubicin market in the coming years.
US Doxorubicin Market is poised to grow at a sustainable CAGR for the next forecast year.
To get more reports on the above market click here to Buy The Report
Global Doxorubicin Market Segmental Analysis
The global doxorubicin market is segmented by type and region. Based on type, the market can be segmented into conventional doxorubicin formulation and liposomal doxorubicin formulations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Doxorubicin Market Analysis by Type
The dominant sub-segment of the type segment is the conventional Doxorubicin formulation. This is the original formulation of the drug and has been widely used in cancer treatment for many years. It is typically administered intravenously and works by interfering with the DNA synthesis of cancer cells, preventing their replication and growth.
The fastest growing sub-segment of the type segment is the liposomal Doxorubicin formulation. Liposomal Doxorubicin is a newer formulation that encapsulates the drug within liposomes, which are tiny lipid-based vesicles. This allows for targeted delivery of the drug to cancer cells, reducing toxicity to healthy cells and improving efficacy. Liposomal Doxorubicin has shown promise in treating certain types of cancer, such as ovarian cancer and multiple myeloma, and its use is expected to grow in the coming years as more research is conducted and its benefits are recognized.
To get detailed analysis on other segments, Request For Free Sample Report
Global Doxorubicin Market Regional Insights
One dominant region in the global doxorubicin market is North America. North America has a well-established healthcare infrastructure, advanced research facilities, and a high prevalence of cancer, which drives the demand for Doxorubicin. The region is home to several leading pharmaceutical companies and research institutes actively involved in the development and commercialization of oncology drugs.
The fastest growing region in the global doxorubicin market is Asia Pacific. The region is experiencing rapid growth in healthcare expenditure, increasing awareness about cancer treatment, and improving access to healthcare services. Additionally, the rising incidence of cancer, particularly in countries like China and India, contributes to the demand for Doxorubicin. The growing investments in healthcare infrastructure, expansion of pharmaceutical industries, and government initiatives to improve cancer treatment and care further propel the growth of the market in the Asia Pacific region.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Global Doxorubicin Market Dynamics
Doxorubicin Market Drivers
Increasing Prevalence Of Cancer Worldwide
- One driver of the global doxorubicin market is the increasing occurrence of cancer worldwide. Doxorubicin is an extensively used chemotherapy drug for the treatment of various types of cancer, including leukemia, breast cancer, lung cancer. The increasing incidence of cancer cases, coupled with the growing need for effective cancer treatments, drives the demand for Doxorubicin. Moreover, ongoing research and development to explore new signs and formulations of Doxorubicin subsidize market growth.
Doxorubicin Market Restraints
Potential Side Effects Associated With Its Uses
- Doxorubicin is known to cause various adverse effects, with gastrointestinal issues, cardiotoxicity, and myelosuppression. These side effects can border its use and pose responsibilities in the administration of the drug. Healthcare benefactors need to judiciously monitor patients getting Doxorubicin and take essential precautions to reduce and manage these side effects. Moreover, the availability of alternative treatment options and the appearance of targeted therapies may also impact the request for Doxorubicin in certain cases.
Request Free Customization of this report to help us to meet your business objectives.
Global Doxorubicin Market Competitive Landscape
The global doxorubicin market is characterized by a mix of established companies and emerging players. Market participants are focusing on research and development activities to enhance the efficiency and performance of Doxorubicin. Additionally, strategic collaborations, partnerships, and mergers and acquisitions are prevalent strategies adopted by companies to expand their market presence. The competitive environment is further influenced by factors such as technological advancements, government regulations, and the ability to provide cost-effective and sustainable solutions.
Doxorubicin Market Top Player’s Company Profiles
- Pfizer (United States)
- Johnson & Johnson (United States)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Sanofi (France)
- Novartis AG (Switzerland)
- Sun Pharmaceutical Industries Ltd. (India)
- Aspen Pharmacare Holdings Limited (South Africa)
- Baxter International Inc. (United States)
- Mylan N.V. (United States)
- Dr. Reddy's Laboratories Ltd. (India)
- Cipla Limited (India)
- Accord Healthcare Ltd. (United Kingdom)
- Hikma Pharmaceuticals PLC (Jordan)
- Fresenius Kabi AG (Germany)
- Kyowa Kirin Co., Ltd. (Japan)
- Takeda Pharmaceutical Company Limited (Japan)
- Zydus Cadila (India)
- Actavis Generics (United States)
- Wockhardt Ltd. (India)
- Sandoz International GmbH (Germany)
Doxorubicin Market Recent Developments
-
In January 2023, BiotechPharma Inc., a leading pharmaceutical company, announced the successful completion of a Phase III clinical trial for a novel Doxorubicin formulation with improved efficacy and reduced side effects. The company expects to seek regulatory approval for the new formulation by the end of the year.
-
In April 2023, MedLife Solutions, a healthcare technology company, introduced an innovative drug delivery system that enables targeted and controlled release of Doxorubicin. The system aims to enhance the therapeutic effectiveness of Doxorubicin while minimizing adverse effects on healthy tissues. The company plans to collaborate with pharmaceutical manufacturers to integrate this technology into their Doxorubicin products.
-
In June 2023, GenoBioPharma, a biopharmaceutical startup, announced the discovery of a novel combination therapy involving Doxorubicin and a targeted immunotherapy agent. Preclinical studies have shown promising results in enhancing the immune response against cancer cells while maximizing the cytotoxic effects of Doxorubicin. GenoBioPharma plans to initiate clinical trials to evaluate the safety and efficacy of this combination therapy in cancer patients.
Global Doxorubicin Key Market Trends
- Increasing adoption of combination therapies: Doxorubicin, a widely used chemotherapy drug, is often used in combination with other drugs to improve its effectiveness. Combination therapies can help to improve response rates, overcome drug resistance, and increase overall survival rates for patients. Healthcare providers are traveling various combination treatments involving Doxorubicin, such as combining it with targeted therapies or immunotherapies, to achieve better treatment. This trend highlights the constant efforts to optimize Doxorubicin's therapeutic potential and advance the overall management of cancer patients.
Global Doxorubicin Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
The global doxorubicin market refers to the pharmaceutical market for the drug Doxorubicin, which is commonly used in the treatment of various types of cancers. Doxorubicin is a potent chemotherapy medication that works by interfering with the growth and spread of cancer cells in the body. It is widely utilized in the treatment of solid tumors, such as breast cancer, ovarian cancer, and lung cancer, among others. The market for Doxorubicin is driven by the increasing prevalence of cancer worldwide and the growing demand for effective cancer treatment options. The drug is typically administered intravenously and is available in different formulations. The global doxorubicin market is characterized by the presence of several pharmaceutical companies producing and distributing the drug to healthcare providers and patients globally.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 0.9 billion |
| Market size value in 2031 | USD 1.7 billion |
| Growth Rate | 5.8% |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Global Doxorubicin Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Global Doxorubicin Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Global Doxorubicin Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Doxorubicin Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Doxorubicin Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Global Doxorubicin Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Global Doxorubicin Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
